After a challenging year, Pool Corp's shares have shown a notable uptick over the past month, reigniting the debate over its valuation. With a significant gap between its current price and analyst targets, investors are weighing short-term momentum against longer-term headwinds in the housing and outdoor living sectors.
H.C. Wainwright has trimmed its price target on Genmab following mixed Phase 3 results for its lymphoma drug EPKINLY, though maintains a Buy rating, citing precedent and ongoing trials.
Keefe Bruyette trimmed its price target on Pagaya Technologies (PGY) to $35, while maintaining an Outperform rating. The adjustment comes despite the AI-driven lending platform reporting robust Q3 growth and a record partner pipeline.
Truist Securities has increased its price target for Nuvation Bio, highlighting the promising early commercial traction of its oncology drug Ibtrozi, which is outpacing competitors in the ROS1 inhibitor space.
DA Davidson joins Morgan Stanley in lowering price targets for language-learning app Duolingo, citing data suggesting daily active user growth may fall short of expectations despite a strong start to the year.
UBS has launched coverage of Arcellx with a Buy rating and a $100 price target, signaling growing Wall Street confidence in a biotech sector recovery and spotlighting the company's promising CAR-T therapy for multiple myeloma.
Bank of America leads a wave of analyst upgrades for DigitalOcean, citing the viral success of its AI agent 'Clawdbot' and the company's strategic positioning in the burgeoning agentic AI market for developers.
In a volatile market, certain low-priced Asian stocks are drawing attention not just for their valuation, but for underlying financial strength. We examine three such companies—from healthcare in New Zealand to property services in Greater China—that defy the typical 'penny stock' stereotype with solid fundamentals.
Shares of Brookdale Senior Living (BKD) rallied sharply, reaching their highest level since 2016, fueled by a significant price target increase from RBC Capital and optimistic preliminary earnings guidance for 2025.
Shares of water heater and boiler manufacturer A. O. Smith have gained significant momentum, closing recently at $73.17. This rally has analysts and investors re-examining the company's fundamentals to determine if the stock remains undervalued or if the market has already priced in its growth prospects.
Canopy Growth's shares have plummeted over 99% in five years, yet analysts warn its challenges run deeper than its stock price suggests. Despite recent U.S. regulatory changes, structural industry headwinds and the company's own track record make it a speculative play at best.
EPAM Systems' stock has surged over 30% in three months, riding a wave of AI optimism. Yet, this rebound contrasts sharply with longer-term declines, leaving investors to weigh if the current price fully reflects future growth or overlooks persistent risks in the IT services sector.
As SoFi Technologies' stock price retreats from recent highs, investors are weighing the fintech's strong growth against its premium valuation in a volatile market.
Meta Platforms' stock has surged nearly 300% over three years, fueled by aggressive AI investments and cost discipline. As shares hover near record highs, investors are asking: does the current price still offer value, or has the rally priced in all future growth? A deep dive into valuation metrics suggests the story may be more nuanced than headlines imply.
As major indexes climb and oil prices fluctuate, investors are turning to dividend payers for reliable income. We analyze three stocks with yields between 3% and 3.5%, examining their sustainability and growth prospects.
Exxon Mobil's fourth-quarter results surpassed expectations, driven by record production in the Permian Basin and Guyana alongside significant cost savings. While the strong performance has propelled the stock higher, analysts are divided on whether its current valuation fully prices in future growth or exposes investors to downside risk.
Despite a sharp sell-off in its shares, HubSpot reports a surge in new contract signings and projects an expanding free cash flow margin, signaling underlying operational strength even as investors remain wary.
Shoppers are bracing for another wave of price increases as new import taxes take effect, targeting a range of everyday items from spirits to seafood. Experts warn the hikes will squeeze household budgets and force tough choices at the supermarket.
Stephens lowers price target on Cal-Maine Foods (CALM) citing near-term oversupply pressures, but the egg producer's long-term strategy remains focused on expanding its cage-free capacity through acquisition.
A deep dive into valuation metrics suggests Martin Marietta Materials (MLM) shares may be pricing in an overly optimistic outlook for construction growth, with key models indicating potential overvaluation.
